Period loss, or amenorrhea, affects approximately 3% to 4% of women of reproductive age. It can be the body’s response to an ...

The program of therapy prescribed for you depends on several factors including: tumor size, lymph node status, cell type, hormone receptor tests, cell growth patterns, your age and health, menopausal ...

Tracking plant hormones. Using an innovative combination of single-cell RNA sequencing and long-term live-cell imaging, the ...

Scientists at the National Institutes of Health (NIH) have found that two common types of hormone therapy may alter breast ...

I n 2016, Colinda Scheele, a cancer biologist at Catholic University Leuven, was studying how chemotherapy affects breast cancer cells in mice.However, she observed an inconsistency: Some cell ...

Sickle cell 'crises' linked to menstrual cycle; Years of 'confusion and debate' are over — research finds hormone therapy is good for women's hearts in early menopause ...

In 2002, a well-intentioned but flawed study upended medical care for middle-aged women. It suggested that hormone therapy, then the gold standard to treat menopausal symptoms, led to higher risks ...

Hormonal therapy might be a low-cost, safe fertility treatment, study suggests 01:19. BOSTON - Fertility treatments, especially IVF, can be expensive and taxing but a simple hormone treatment ...

The study involved scanning a 26-year-old's brain 40 times in 30 days. Each magnetic resonance imaging (MRI) scan was collected at either 7 a.m. or 8 p.m., which is when levels of steroid hormones ...

In 2025, clinics like AlphaMan, a men’s health center specializing in hormone optimization, are rethinking how testosterone therapy fits into modern masculinity. Because when it comes to low ...

Taking hormone replacement at the right time in midlife reduces the risk of dementia and Alzheimer’s disease by 23% to 32%, a new meta-analysis found.

Men in the post-cycle therapy group achieved normalized hormone levels at 13.3 weeks after stopping steroids compared with 18.7 weeks for those who did not use post-cycle therapy (P < .01).